Charles Evan Ballantyne - Net Worth and Insider Trading
Charles Evan Ballantyne Net Worth
The estimated net worth of Charles Evan Ballantyne is at least $1,553 dollars as of 2024-11-13. Charles Evan Ballantyne is the CFO of Agenus Inc and owns about 500 shares of Agenus Inc (AGEN) stock worth over $1,553. Details can be seen in Charles Evan Ballantyne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Evan Ballantyne has not made any transactions after 2015-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Evan Ballantyne
Charles Evan Ballantyne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Evan Ballantyne owns 3 companies in total, including Agenus Inc (AGEN) , Theriva Biologics Inc (TOVX) , and Gain Therapeutics Inc (GANX) .
Click here to see the complete history of Charles Evan Ballantyne’s form 4 insider trades.
Insider Ownership Summary of Charles Evan Ballantyne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGEN | Agenus Inc | 2015-09-25 | Chief Financial Officer |
| TOVX | Theriva Biologics Inc | 2012-02-06 | CHIEF FINANCIAL OFFICER |
| GANX | Gain Therapeutics Inc | 2023-04-10 | Chief Financial Officer |
Charles Evan Ballantyne Latest Holdings Summary
Charles Evan Ballantyne currently owns a total of 1 stock. Charles Evan Ballantyne owns 500 shares of Agenus Inc (AGEN) as of September 25, 2015, with a value of $1,553.
Latest Holdings of Charles Evan Ballantyne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGEN | Agenus Inc | 2015-09-25 | 500 | 3.11 | 1,553 |
Holding Weightings of Charles Evan Ballantyne
Charles Evan Ballantyne Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Evan Ballantyne has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the acquisition of 500 shares on September 25, 2015, which cost Charles Evan Ballantyne around $50,500.
Insider Trading History of Charles Evan Ballantyne
- 1
Charles Evan Ballantyne Trading Performance
GuruFocus tracks the stock performance after each of Charles Evan Ballantyne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Evan Ballantyne is -5.16%. GuruFocus also compares Charles Evan Ballantyne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Evan Ballantyne within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Evan Ballantyne's insider trading performs compared to the benchmark.
Performance of Charles Evan Ballantyne
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.2 | | | | | |
| Relative Return to S&P 500(%) | -7.65 | | | | | |
Charles Evan Ballantyne Ownership Network
Ownership Network List of Charles Evan Ballantyne
Ownership Network Relation of Charles Evan Ballantyne
Charles Evan Ballantyne Owned Company Details
What does Agenus Inc do?
Who are the key executives at Agenus Inc?
Charles Evan Ballantyne is the Chief Financial Officer of Agenus Inc. Other key executives at Agenus Inc include Chairman & CEO Garo H Armen , Chief Medical Officer Steven J O'day , and VP Finance Christine M Klaskin .
Agenus Inc (AGEN) Insider Trades Summary
Over the past 18 months, Charles Evan Ballantyne made no insider transaction in Agenus Inc (AGEN). Other recent insider transactions involving Agenus Inc (AGEN) include a net purchase of 500,000 shares made by Garo H Armen , and a net purchase of 25,000 shares made by Ulf Wiinberg .
In summary, during the past 3 months, insiders sold 0 shares of Agenus Inc (AGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agenus Inc (AGEN) were sold and 26,250 shares were bought by its insiders, resulting in a net purchase of 26,250 shares.
Agenus Inc (AGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agenus Inc Insider Transactions
Charles Evan Ballantyne Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Evan Ballantyne. You might contact Charles Evan Ballantyne via mailing address: 27 Hearthstone Road, Hopkinton Ma 01748.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
